AMD hits multi-year highs on surprise Q2 profit >>> READ MORE

Fusion-io’s Shocker Could Make It a Bargain

Jan 31, 2013, 1:23 pm EDT
Fusion-io’s Shocker Could Make It a Bargain

Fusion-io (NYSE:FIO), a top provider of flash storage systems, shocked investors Thursday with its fiscal second-quarter results. The stock is currently off by 17% to $16.88 in today’s trading. However, the shares had already been deteriorating — they were priced at nearly $30 in early October.

What happened? Fusion-io said delays in orders from Facebook (NASDAQ:FB) and Apple (NASDAQ:AAPL) will last about two quarters. These companies represent a whopping 51% of revenues.

So, Fusion-io had no choice but to put out weak guidance. For Q3, it forecasts revenues of $80 million and an operating loss of $10 million to $15 million. Keep in mind that the Street consensus was for revenues of $137.7 million and operating profits of $16.7 million. Read 

A Strong IPO for TRI Pointe Homes

Jan 31, 2013, 11:27 am EDT
A Strong IPO for TRI Pointe Homes

Homebuilder TRI Pointe Homes (NYSE:TPH) launched its IPO today with no small amount of success. The deal got done at $17 per share — higher than the initial price range of $14-$16 — and shares have gained about 16% to above $19.50 so far in Thursday trading.

Lead underwriters included Citigroup (NYSE:C), Deutsche Bank (NYSE:DB) and FBR.

TRI Pointe got its start back in April 2009 during the depths of the real estate depression. The founders realized there was a big opportunity to create a next-generation platform with a focus on growth markets and low-cost approaches, and the strategy paid off. Read 

Facebook Has Transformed Into a Mobile Ninja

Jan 31, 2013, 10:56 am EDT
Facebook Has Transformed Into a Mobile Ninja

On the fourth-quarter earnings call, Facebook‘s (NASDAQ:FB) Mark Zuckerberg put things into perspective: “Today there’s no argument. Facebook is a mobile company.”

Hey, remember when Facebook went public back in May, and there was much alarm about its mobile business? Well, that’s a thing of the past. The fact is Zuckerberg has pulled off an impressive transformation.

In Q4, mobile advertising accounted for 23% of total ad revenues, up from 14% in the third quarter. A big part of this came from putting “sponsored stories” in News Feeds as well as getting aggressive with “app install” ads. Read 

Get Ready for a Facebook Earnings Blowout

Jan 30, 2013, 11:51 am EDT

Facebook’s (NASDAQ:FB) botched IPO seems to be a thing of the past. Since early November, the company’s shares are up a sizzling 63%.

Investors are excited about renewed growth, especially as Facebook focuses on monetizing its massive mobile traffic. And, as I’m sure you know, after the market closes today, we’ll get more details on the company’s efforts. Facebook is scheduled to report its Q4 results.

The Wall Street consensus is for revenues of $1.53 billion for the quarter, which would be a 34% year-over-year increase. Full-year earnings are expected to come in at $394.4 million, or 52 cents per share. Read 

Facebook May Owe You $10

Jan 29, 2013, 10:14 am EDT
Facebook May Owe You $10

Over the weekend, you may have received an email about getting $10 from Facebook (NASDAQ:FB). While such messages are usually spam or scams, this one is actually legit.

It’s part of a legal settlement over Facebook’s “Sponsored Stories” system, which based ads on the Likes of users — without their permission or payment. The company has set aside $20 million in a fund to pay the obligations.

But of course, there are some important extra details. For example, about $8 million will go to attorney’s fees. This is always the first priority. Read 

Zoetis: The Biggest IPO Since Facebook

Jan 28, 2013, 11:36 am EDT
Zoetis: The Biggest IPO Since Facebook

After a sparse week that saw just two deals — though good ones, with Bright Horizons (NYSE:BFAM) gaining 29% and LipoScience (NASDAQ:LPDX) climbing 16% — we’re set to double that number in the next few days, with four deals set to hit the market. Here’s a look at each: Zoetis

Zoetis (NYSE:ZTS) is a spinoff of Pfizer’s (NYSE:PFE) animal health business, and is set to be the largest deal since Facebook (NASDAQ:FB) went public. Zoetis plans to issue 86.1 million shares at a range of $22 to $25, potentially raising $2.2 billion. (Facebook’s deal raised $16 billion).

Zoetis is the No. 1 operator in the industry, selling more than 300 products across 120 countries. For the first nine months of 2012, revenues increased by only 1.7% to $3.16 billion, but operating income spiked by 75% to $636 million. Read 

1 2 3 8